The single-cell analysis market is poised for significant growth, with an expected increase from USD 3.7 billion in 2024 to USD 6.9 billion by 2029, at a compound annual growth rate (CAGR) of 13.6%. This growth trajectory is largely fueled by burgeoning interest in personalized medicine and rising R&D investments in the pharmaceutical and biotechnology sectors.
Drivers of Market Growth
The market is driven by several factors, including technological advancements, cancer prevalence, and R&D growth in complex diseases. The use of advanced sequencing techniques has also driven growth in the market. Additionally, the increasing focus on personalized medicine due to rising cancer incidences further strengthens the market’s growth.
Research Applications Lead in 2023
In 2023, the research application segment dominated, driven by its utility in cancer, immunology, neurology, and stem cell research. The growing prevalence of cancer has heightened the demand for advanced therapeutic options that leverage single-cell analysis, resulting in substantial market uptake.
Flow Cytometry: A Technological Front-runner
Flow cytometry emerged as the leading technology segment in 2023, attributed to its comprehensive applicability in performing multifaceted measurements in heterogeneous mixtures. The technology’s widespread acceptance is further cemented by the persistent adoption of advanced methods for cell identification and characterization, thereby augmenting market expansion.
US Leads Regional Market Dynamics
The United States spearheads the global single-cell analysis market, capitalizing on its robust biopharmaceutical industry and substantial research funding. The healthcare infrastructure in the US, along with a strong presence of biopharmaceutical entities, significantly propels market growth.
Research Methodology and Company Insights
Primary interviews conducted comprise 70% supply-side and 30% demand-side respondents, encompassing managers, CXOs & directors, and executives, across regions like North America, Europe, and Asia-Pacific. The report encompasses profiles of pivotal players, including Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, and BD, among others.
Key Benefits of the Report
This comprehensive report offers close revenue approximations for the overall market and its subsegments, assisting market leaders and new entrants alike with competitor analysis and strategic positioning. It delivers insights into market drivers, constraints, opportunities, and industry challenges.
Key Attributes:
- Report Attribute
- Details
- No. of Pages
- Forecast Period
- Estimated Market Value (USD) in 2024
- Forecasted Market Value (USD) by 2029
- Compound Annual Growth Rate
- Regions Covered
Market Dynamics
Drivers
- Technological Advancements in Single-Cell Analysis Products
- Rising Prevalence of Cancer
- Increasing R&D in Pharmaceutical and Biotechnology Industries
- Growth in Stem Cell Research
- Growing Focus on Personalized Medicine
Restraints
- High Cost of Single-Cell Analysis Products
Opportunities
- High Growth Potential of Single-Cell Sequencing
- Integration of Microfluidics in Single-Cell Analysis
- Rising Potential in Emerging Asian Markets
Challenges
- Lack of Standardization in Protocols and Quality Control Procedures
- Technical Limitations of Single-Cell Analysis
- Mounting Ethical and Privacy Concerns
Company Profiles
- BD
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Merck KGaA
- Agilent Technologies, Inc.
- Qiagen
- Illumina, Inc.
- Bio-Rad Laboratories, Inc.
- Diasorin S.P.A.
- Standard Biotools
- Tecan Trading AG
- Sartorius AG
- Corning Incorporated
- Cytek Biosciences
- Takara Bio Inc.
- Biomerieux
- Revvity
- Bio-Techne
- Pacbio
- Bruker
- Promega Corporation
- Oxford Nanopore Technologies PLC
- Singleron Biotechnologies
- Cell Microsystems
- Nanocellect Biomedical
- Rarecyte, Inc.
- Bico
- Menarini Group
This rewritten article presents a comprehensive overview of the single-cell analysis market, including its growth prospects, drivers, restraints, opportunities, and challenges. The article provides detailed analysis of the market, including the research application segment, flow cytometry, and the US market dynamics. It also highlights key companies operating in the market and provides insights into the market’s competitive landscape. The article concludes with a summary of the key attributes of the report, including its scope, methodology, and benefits.
news is a contributor at MarketMelt. We are committed to providing well-researched, accurate, and valuable content to our readers.
